Markey STRONG for UKNow_0.jpg

LEXINGTON, Ky. (Nov. 23, 2021) — For this “UK at the Half,” Kathleen O’Connor, Ph.D., researcher and associate director of cancer education and mentoring at the University of Kentucky Markey Cancer Center, and current UK senior and program participant, Daniela Nakinoja, discuss the value of the Markey STRONG Scholars program to foster diversity in cancer research.

210809Barton-Baxter18_lowerres.jpg

LEXINGTON, Ky. (Nov. 22, 2021) — What makes UK the university of, for and with Kentucky? 

The answer is our people.  

arise.jpg

LEXINGTON, Ky. (Nov. 19, 2021) — A new training program at the University of Kentucky will help develop the next generation of scientists needed to reduce Kentucky’s burden of high cancer incidence and mortality rates.

Vanderford with ACTION students_0_0.png

LEXINGTON, Ky. (Nov. 17.

190814DONNAWILCOCK259 copy (2).jpeg

LEXINGTON, Ky. (Nov. 11, 2021) — Researchers at the University of Kentucky’s Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million. 

BTB-UKNow_0_102.jpg

LEXINGTON, Ky. (Nov. 8, 2021) — The University of Kentucky is proud to be the home of global leaders in aging and brain research, all striving toward the same goal: finding a stop to the sixth leading cause of death in the U.S.: Alzheimer’s disease.

UK’s Sanders-Brown Center on Aging has been around for nearly half a century, helping lead the way in Alzheimer’s and dementia research. Sanders-Brown Center Director Linda Van Eldik, Ph.D., firmly believes they will find a cure through the work going on right here on the UK campus.

161011JILLKOLESAR-MC092_0.JPG

LEXINGTON, Ky. (Nov. 2, 2021) — A recent study shows that patients with non-small cell lung cancer reviewed by the University of Kentucky Markey Cancer Center’s Molecular Tumor Board experience improved outcomes, even if they reside in rural Appalachian Kentucky.

GettyImages-1281725866 (1).jpg

LEXINGTON, Ky. (Nov. 2, 2021) — The program is set and registration is open for the 11th annual Sanders-Brown Markesbery Symposium on Aging and Dementia. The event is named in honor and memory of the late William R. Markesbery, M.D., founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center.

GettyImages-1013858904 (2).jpg

LEXINGTON, Ky. (Oct. 26, 2021) — Imagine being at a restaurant with your family to celebrate a birthday when your loved one orders something obscure with total confidence. It is a situation that, based on how others respond, can quickly escalate into an unpleasant experience for everyone around. It is scenarios like this one that Dementia Friendly Lexington is working to equip local businesses to handle.

211012GaurangVaidya81.jpg

LEXINGTON, Ky. (Oct. 26, 2021) — When it comes to medical diagnoses, retired nurse Sue Routin, 65, says she’s just about seen it all.

“Thanks to my experience in health care, I am generally well-versed in the wide world of ailments,” said Routin, a Stanford, Kentucky, resident who worked in nursing for 23 years. Day in and day out, it was her job to recognize a problem, evaluate symptoms and help determine treatment.

Chambers_MaraD_MD__04 USE THIS ONE.jpg

Mara Chambers, MD, is an associate professor of medicine in the division of medical oncology with an interest in breast cancer diagnosis and treatment. She also serves as chair of the Markey Cancer Center’s Clinical Care and Research Team (CCART) for breast cancer and is on the UK College of Medicine Admissions Committee.

Transportation photo ACS.jpg

LEXINGTON, Ky. (Oct. 21, 2021) — The University of Kentucky Markey Cancer Center has been awarded a transportation grant from the American Cancer Society. The funds will help alleviate the financial burden of transportation costs for cancer patients in Kentucky.

GettyImages-868507104.jpg

LEXINGTON, Ky. (Oct. 21, 2021) — A recent University of Kentucky College of Medicine study found that young adults from vulnerable communities are more likely to be exposed to tobacco marketing in their daily lives than are young adults outside these communities.

Screen Shot 2021-10-19 at 11.54.44 AM.png


The University of Kentucky College of Medicine has received the 2021 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education.

060421Rankin5_0.jpg

LEXINGTON, Ky. (Oct. 11, 2021) — For this "UK at the Half," Michael D. Rankin, M.D., a 1980 graduate of the University of Kentucky College of Medicine discusses his time at UK and how it inspired him to lead the charge for the college's growth. 

During the UK game on Saturday, Rankin was recognized for his monumental $22 million gift commitment that will transform medical education in Kentucky.

GettyImages-1334574170.jpg

LEXINGTON, Ky. (Oct. 8, 2021) — A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer’s disease pathology.

Markey Loop_3.png

LEXINGTON, Ky. (Oct. 6, 2021) — A new study from the lab of University of Kentucky Markey Cancer Director Mark Evers, M.D., demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine.

GettyImages-683962672.jpg

LEXINGTON, Ky. (Oct. 6, 2021) — Recent work from the University of Kentucky College of Medicine published in Cell Press discusses an essential signaling pathway that causes metabolic dysfunction including insulin resistance and obesity.

GettyImages-531920918.jpg

LEXINGTON, Ky. (Oct. 5, 2021) — University of Kentucky College of Medicine researchers were part of a new study that gives insight into how limb development evolved in vertebrates.

Markey Loop_2.png

LEXINGTON, Ky. (Sept. 28, 2021) — A new study from University of Kentucky Markey Cancer researchers demonstrates a combination of two drugs may be useful to treat ovarian cancers that are resistant to paclitaxel.